CHC (4164.TW) monthly revenue, September 2026
CHC reported revenue of NT$0.51bn for September 2026, up 54.6% from the previous month and down 4.1% from a year earlier. Year-to-date revenue was NT$3.50bn, up 9.7% year on year. It ranked 112 of 159 companies in the Biotechnology and Medical Care industry by year-on-year growth.
| Month | Revenue NT$bn | MoM % | YoY % |
|---|---|---|---|
| September 2026 | 0.51 | 54.6 | -4.1 |